U.S. Banks Stock News

If you are wondering whether N-able's share price around US$7.31 actually reflects its underlying worth, you are not alone. This article is built to help you size that up clearly. Over the past week the stock is roughly flat at a 0.1% return, but that sits against a 4.2% decline over 30 days and a 19.7% decline over the past year, which can change how investors view both its potential and its risks. Recent coverage has focused on how N-able is positioned within the broader software and IT...

If you have been wondering whether P10 is priced attractively right now, you are not alone. Many investors are asking the same question about what they are really paying for with this stock. P10 shares last closed at US$10.33, with recent returns of 4.4% over the past week, 1.2% over the past month, 4.4% year to date, and a 17.6% decline over the past year and 7.6% decline over three years. Recent market attention on P10 has been shaped by ongoing discussion around its role in the...

Immuneering Corporation recently reported updated Phase 2a data showing encouraging overall survival, response, and safety outcomes for its atebimetinib plus modified gemcitabine/nab-paclitaxel regimen in previously untreated pancreatic cancer patients, and confirmed plans to begin a pivotal Phase 3 trial in mid-2026. A key nuance is that the reported survival benefit is based on comparisons to historical MPACT trial benchmarks rather than a head-to-head control arm, which may influence how...

Soho House & Co (SHCO) has recently drawn investor attention after a period of mixed share performance, with the stock showing a small positive 1 year total return alongside negative moves over the past week, month and past 3 months. See our latest analysis for Soho House & Co. The recent 1 day share price return of 2.59% decline, alongside weaker 7 day and 30 day share price returns, suggests fading short term momentum, even as the 3 year total shareholder return of 48.78% points to a...

If you are wondering whether Bank of N.T. Butterfield & Son at around US$50.36 is priced attractively or not, the key question is how that share price stacks up against its underlying value. The stock has returned 1.3% over the last 7 days, 0.0% over the past 30 days and 1.3% year to date, while the 1 year and 3 year returns sit at 49.8% and 87.7% respectively. This makes the current level especially interesting for anyone thinking about risk and reward. Recent trading interest has been...

Grid Dynamics Holdings (GDYN) is back on investors’ radar after entering a multi-year collaboration with Amazon Web Services centered on generative AI solutions for enterprise clients, framed against fresh insider stock sales and equity plan changes. See our latest analysis for Grid Dynamics Holdings. The AWS collaboration arrives after a choppy period for shareholders, with a 25% 90 day share price return contrasted by a 53.17% decline in 1 year total shareholder return. Recent momentum is...

The Oncology Institute, Inc. recently promoted Rakesh Panda to Chief Information Officer and Nolan Mariano to Chief People Officer, and added RadNet CFO Mark Stolper to its Board of Directors, bringing deeper technology, cybersecurity, people operations, and healthcare finance expertise into its leadership ranks. These leadership moves underscore the company’s focus on AI-enabled care, data privacy, and organizational strength as it refines its value-based cancer care model. Next, we’ll...

Greenbrier Companies (GBX) opened fiscal Q1 2026 with revenue of US$706.1 million and basic EPS of US$1.18, alongside trailing twelve month revenue of US$3.1 billion and EPS of US$5.96 that sit against a net profit margin of 6.0% over the past year. Over recent quarters, the business has seen revenue move from US$875.9 million and EPS of US$1.77 in Q1 2025 through to US$759.5 million and EPS of US$1.19 in Q4 2025, giving investors a clearer view of how the latest print fits into a year of...

Tilray Brands (TLRY) just posted Q2 2026 results with revenue of US$217.5 million, a basic EPS loss of US$0.41, and net income loss of US$44.9 million, putting the focus squarely on how the income statement is evolving through the year. The company has seen quarterly revenue move between US$200.0 million and US$224.5 million over the past six reported periods, while basic EPS has ranged from a small loss of roughly US$0.00 to much larger quarterly losses in 2025 and 2026. This keeps attention...

When close to half the companies in the United States have price-to-earnings ratios (or "P/E's") below 19x, you may...

If you are wondering whether UMH Properties is attractively priced or not, this article walks through the key numbers so you can judge the value for yourself. The share price recently closed at US$16.08, with returns of 1.1% over the last week, 5.2% over the last month, 1.1% year to date, 8.9% over three years, and 34.2% over five years, while the 1 year return sits at a 7.0% decline. Recent coverage has focused on UMH Properties' position within the real estate sector and how investors are...

Howard Marks put it nicely when he said that, rather than worrying about share price volatility, 'The possibility of...

Howard Marks put it nicely when he said that, rather than worrying about share price volatility, 'The possibility of...

AngioDynamics (ANGO) is back on investors’ radar after its Med Tech platforms helped deliver stronger quarterly results, prompting management to raise full year revenue and profitability guidance while outlining an upcoming CEO transition. See our latest analysis for AngioDynamics. Even with the raised guidance and progress in Med Tech platforms, AngioDynamics’ 7 day share price return of 21.73% and 30 day share price return of 23.63% suggest recent momentum has faded, aligning with a 1 year...

As the U.S. stock market continues to soar, with the S&P 500 reaching new all-time highs following a drop in unemployment rates, investors are keenly observing opportunities within the small-cap sector. In this dynamic environment, identifying promising stocks requires a focus on companies that can navigate economic shifts and capitalize on emerging trends.

When we're researching a company, it's sometimes hard to find the warning signs, but there are some financial metrics...

While some investors are already well versed in financial metrics (hat tip), this article is for those who would like...

Arbe Robotics recently announced at CES 2026 that it is combining its automotive-grade ultra‑HD radar with NVIDIA’s accelerated computing to create an AI-based perception platform designed for hands-off, eyes-off driving, featuring over 20,000 detections per frame and more than 300 meters of range in varied weather conditions. A distinctive aspect of this development is how the dense radar point cloud, processed on NVIDIA’s in-vehicle computing, is being used to build AI-based occupancy...

It's nice to see the Oxford Industries, Inc. ( NYSE:OXM ) share price up 13% in a week. But over the last three years...

Expro Group Holdings N.V.'s ( NYSE:XPRO ) price-to-earnings (or "P/E") ratio of 24.5x might make it look like a sell...

Build-A-Bear Workshop (NYSE:BBW) has had a great run on the share market with its stock up by a significant 26% over...

It's not a stretch to say that Taboola.com Ltd.'s ( NASDAQ:TBLA ) price-to-sales (or "P/S") ratio of 0.7x right now...

Many investors are still learning about the various metrics that can be useful when analysing a stock. This article is...

Even when a business is losing money, it's possible for shareholders to make money if they buy a good business at the...